Protein family
Protein sequence
Protein function
Catalytic activity
EC number
EC number description
2.7.10.2
Transferases;
Transferring phosphorus-containing groups;
Protein-tyrosine kinases;
non-specific protein-tyrosine kinase
2.7.11.1
Transferases;
Transferring phosphorus-containing groups;
Protein-serine/threonine kinases;
non-specific serine/threonine protein kinase
PDB | Resolution (Å) | PDB name |
---|---|---|
2N7Z | Solution structure of RIP2 CARD | |
2N83 | p75NTR DD:RIP2 CARD | |
4C8B | 2.75 | Structure of the kinase domain of human RIPK2 in complex with ponatinib |
5AR2 | 2.44 | RIP2 Kinase Catalytic Domain (1 - 310) |
5AR3 | 3.23 | RIP2 Kinase Catalytic Domain (1 - 310) complex with AMP-PCP |
5AR4 | 2.7 | RIP2 Kinase Catalytic Domain (1 - 310) complex with SB-203580 |
5AR5 | 2.66 | RIP2 Kinase Catalytic Domain (1 - 310) complex with Benzimidazole |
5AR7 | 2.71 | RIP2 Kinase Catalytic Domain (1 - 310) complex with Biaryl Urea |
5AR8 | 2.79 | RIP2 Kinase Catalytic Domain (1 - 310) complex with Biphenylsulfonamide |
5J79 | 2.69 | The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a highly potent and selective inhibitor of RIP2 Kinase, Compound 3 complex |
5J7B | 2.53 | The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a highly potent and selective inhibitor of RIP2 Kinase, GSK583 complex |
5NG0 | 2.0 | Structure of RIP2K(L294F) with bound AMPPCP |
5NG2 | 2.8 | Structure of RIP2K(D146N) with bound Staurosporine |
5NG3 | 2.6 | Structure of inactive kinase RIP2K(K47R) |
5W5J | 2.85 | Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases |
5W5O | 2.89 | Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases. |
5YRN | 4.1 | Structure of RIP2 CARD domain |
6ES0 | 2.38 | Crystal structure of the kinase domain of human RIPK2 in complex with the activation loop targeting inhibitor CS-R35 |
6FU5 | 3.26 | Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18 |
6GFJ | 3.3 | Structure of RIP2 CARD domain fused to crystallisable MBP tag |
6GGS | 3.94 | Structure of RIP2 CARD filament |
6HMX | 2.53 | RIP2 Kinase Catalytic Domain complex with N(4,5dimethyl1Hpyrazol3yl)7methoxy6(2methylpropane2sulfonyl)quinolin4amine |
6RN8 | 2.69 | RIP2 Kinase Catalytic Domain complex with 2(4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)quinazolin7yl)oxy)ethyl phosphate |
6RNA | 2.62 | RIP2 Kinase Catalytic Domain complex with 2({4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)quinazolin7yl}oxy)ethan1ol |
6S1F | 3.11 | Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3 |
6SZE | 2.94 | RIP2 Kinase Catalytic Domain complex with 5-Amino-1-Phenylpyrazole-4-Carboxamide. |
6SZJ | 2.53 | RIP2 Kinase Catalytic Domain complex with 5amino1tertbutyl3(3methoxyphenyl)1H pyrazole4carboxamide. |
6UL8 | 2.68 | RIP2 kinase catalytic domain complex with (5S,6S,8R)-2-(benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8-methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide |
7OBS | 1.8 | Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide |
7OBT | 2.3 | Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide and stabilizer Fusicoccin-A |
8AZA | 3.15 | Structure of RIP2K dimer bound to the XIAP BIR2 domain |
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0035739 | CD4-positive, alpha-beta T cell proliferation |
Biological Process | GO:0070371 | ERK1 and ERK2 cascade |
Biological Process | GO:0007249 | I-kappaB kinase/NF-kappaB signaling |
Biological Process | GO:0007254 | JNK cascade |
Biological Process | GO:0050852 | T cell receptor signaling pathway |
Biological Process | GO:0097202 | activation of cysteine-type endopeptidase activity |
Biological Process | GO:0002250 | adaptive immune response |
Biological Process | GO:0006915 | apoptotic process |
Biological Process | GO:0071223 | cellular response to lipoteichoic acid |
Biological Process | GO:0071225 | cellular response to muramyl dipeptide |
Biological Process | GO:0071224 | cellular response to peptidoglycan |
Biological Process | GO:0019221 | cytokine-mediated signaling pathway |
Biological Process | GO:0050830 | defense response to Gram-positive bacterium |
Biological Process | GO:0033080 | immature T cell proliferation in thymus |
Biological Process | GO:0006954 | inflammatory response |
Biological Process | GO:0045087 | innate immune response |
Biological Process | GO:0031663 | lipopolysaccharide-mediated signaling pathway |
Biological Process | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway |
Biological Process | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway |
Biological Process | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation |
Biological Process | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
Biological Process | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
Biological Process | GO:0046330 | positive regulation of JNK cascade |
Biological Process | GO:0051092 | positive regulation of NF-kappaB transcription factor activity |
Biological Process | GO:0045627 | positive regulation of T-helper 1 cell differentiation |
Biological Process | GO:0002827 | positive regulation of T-helper 1 type immune response |
Biological Process | GO:0043065 | positive regulation of apoptotic process |
Biological Process | GO:0032722 | positive regulation of chemokine production |
Biological Process | GO:0001961 | positive regulation of cytokine-mediated signaling pathway |
Biological Process | GO:0033092 | positive regulation of immature T cell proliferation in thymus |
Biological Process | GO:0032727 | positive regulation of interferon-alpha production |
Biological Process | GO:0032728 | positive regulation of interferon-beta production |
Biological Process | GO:0032731 | positive regulation of interleukin-1 beta production |
Biological Process | GO:0032735 | positive regulation of interleukin-12 production |
Biological Process | GO:0032743 | positive regulation of interleukin-2 production |
Biological Process | GO:0032755 | positive regulation of interleukin-6 production |
Biological Process | GO:0060907 | positive regulation of macrophage cytokine production |
Biological Process | GO:0033138 | positive regulation of peptidyl-serine phosphorylation |
Biological Process | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation |
Biological Process | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation |
Biological Process | GO:0032092 | positive regulation of protein binding |
Biological Process | GO:0031398 | positive regulation of protein ubiquitination |
Biological Process | GO:0045944 | positive regulation of transcription by RNA polymerase II |
Biological Process | GO:0032760 | positive regulation of tumor necrosis factor production |
Biological Process | GO:0032729 | positive regulation of type II interferon production |
Biological Process | GO:1904417 | positive regulation of xenophagy |
Biological Process | GO:0006468 | protein phosphorylation |
Biological Process | GO:0043330 | response to exogenous dsRNA |
Biological Process | GO:0070555 | response to interleukin-1 |
Biological Process | GO:0070671 | response to interleukin-12 |
Biological Process | GO:0070673 | response to interleukin-18 |
Biological Process | GO:0007165 | signal transduction |
Biological Process | GO:0034134 | toll-like receptor 2 signaling pathway |
Biological Process | GO:0034142 | toll-like receptor 4 signaling pathway |
Biological Process | GO:0098792 | xenophagy |
Molecular Function | GO:0005524 | ATP binding |
Molecular Function | GO:0050700 | CARD domain binding |
Molecular Function | GO:0004706 | JUN kinase kinase kinase activity |
Molecular Function | GO:0030274 | LIM domain binding |
Molecular Function | GO:0089720 | caspase binding |
Molecular Function | GO:0042802 | identical protein binding |
Molecular Function | GO:0004715 | non-membrane spanning protein tyrosine kinase activity |
Molecular Function | GO:0042803 | protein homodimerization activity |
Molecular Function | GO:0106310 | protein serine kinase activity |
Molecular Function | GO:0004674 | protein serine/threonine kinase activity |
Molecular Function | GO:0005102 | signaling receptor binding |
Cellular Component | GO:0005737 | cytoplasm |
Cellular Component | GO:0005856 | cytoskeleton |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0005783 | endoplasmic reticulum |
Cellular Component | GO:0032991 | protein-containing complex |
Cellular Component | GO:0031982 | vesicle |
InterPro | InterPro name |
---|---|
IPR000719 | Protein kinase domain |
IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
IPR001315 | CARD domain |
IPR008271 | Serine/threonine-protein kinase, active site |
IPR011009 | Protein kinase-like domain superfamily |
IPR011029 | Death-like domain superfamily |
IPR017322 | Receptor-interacting serine/threonine-protein kinase 2 |
IPR042149 | RIP2, CARD domain |
Pfam | Pfam name |
---|---|
PF00619 | Caspase recruitment domain |
PF07714 | Protein tyrosine and serine/threonine kinase |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-168638 | NOD1/2 Signaling Pathway | Leaf | R-HSA-168256 | Immune System |
R-HSA-202424 | Downstream TCR signaling | Leaf | R-HSA-168256 | Immune System |
R-HSA-209543 | p75NTR recruits signalling complexes | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | Internal node | R-HSA-168256 | Immune System |
R-HSA-450302 | activated TAK1 mediates p38 MAPK activation | Leaf | R-HSA-168256 | Immune System |
R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | Leaf | R-HSA-168256 | Immune System |
R-HSA-5689896 | Ovarian tumor domain proteases | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-9020702 | Interleukin-1 signaling | Internal node | R-HSA-168256 | Immune System |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | Leaf | R-HSA-1643685 | Disease |
Location | ECO term | Pubmed |
---|---|---|
Cytoplasm | ECO:0000269 | PubMed:21887730 |
Endoplasmic reticulum | ECO:0000269 | PubMed:28656966 |